资源 » 参考数据库 » 客户发表文献

至今，GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次，处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果，再次证明GenScript 有能力帮助业内科学家Make research easy.

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies.

Cancer Med. 2019-07;

RosillonDominique，BarilLaurence，Del Rosario-RaymundoMaria Rowena，WheelerCosette Marie，SkinnerSusan Rachel，GarlandSuzanne Marie，SalmeronJorge，Lazcano-PonceEduardo，VallejosCarlos Santiago，StoneyTanya，Ter HarmselBram，LimTimothy Yong Kuei，QuekSwee Chong，MinkinaGalina，McNeilShelly Ann，BouchardCeline，FongKah Leng，MoneyDeborah，IlancheranArunachalam，SavichevaAlevtina，CruickshankMargaret，ChatterjeeArchana，FianderAlison，MartensMark，BozonnatMarie Cecile，StruyfFrank，DubinGary，CastellsaguéXa

Products/Services Used	Details	Operation
Peptide Synthesis	… Isolated splenocytes in R10 medium were counted and added in triplicate wells at 2×105 cells per well. Two sets of peptides spanning the consensus E6/E7 sequence for HPV6 and HPV11 were reconstituted in DMSO (GenScript USA, Piscataway, NJ) …	Get A Quote

摘要

Infections with human papillomavirus (HPV) types 16 and 18 account for ~70% of invasive cervical cancers but the degree of protection from naturally acquired anti-HPV antibodies is uncertain. We examined the risk of HPV infections as defined by HPV DNA detection and cervical abnormalities among women >25 years in the Human Papilloma VIrus Vaccine Immunogenicity ANd Efficacy trial's (VIVIANE， NCT00294047) control arm.